Agilent Technologies Inc. (A)
Agilent beats quarterly revenue estimates on strong demand for lab tools
Life sciences firm Agilent Technologies on Monday beat fourth-quarter revenue estimates, helped by strong demand for medical tools and equipment used in lab research and diagnostic services.
Wall Street Week Ahead
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Beyond analysts' top-and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.
Why Agilent (A) International Revenue Trends Deserve Your Attention
Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
Unveiling Agilent (A) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August
Most MoPay equities and funds offer annual dividends from a $1K investment that exceed their share price, presenting affordable but volatile opportunities. Analyst estimates suggest the top ten MoPay stocks could generate 16% to 104% total returns by August 2026, with an average gain of 30.56%. The 'dogcatcher' strategy identifies high-yield, contrarian picks, but emphasizes caution due to volatility, dividend cuts, and negative free cash flow in some names.
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SVP and CFO Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Michael Ryskin - Bank of America Dan Leonard - UBS Operator Good afternoon.
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
